EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial

Mahdi Mirahmadi iD, Malihe Aghasizadeh iD, Fatemeh Nazifkar iD, Mahla Ghafarian Choubdari iD, Reza Assaran-Darban iD, Shima Tavallaie iD, Hossein Hatamzadeh iD, Gordon Ferns iD, Mohammad Reza Mirinezhad iD, Hamed Baharara iD, Farzin Hadizadeh iD, Majid Ghayour-Mobarhan

Cell Journal · 2023-12 · 25 (12) · 847-853

DOI: 10.22074/cellj.2023.2006158.1353 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cell Journal, 2023-12. Verfasst von Mahdi Mirahmadi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The pathogenesis of metabolic syndrome (MetS) complications involves the excessive production ofreactive oxygen species, inflammation, and endothelial dysfunction. Due to Lycopene, a highly unstable structure andits significant effects on modulating the metabolic system, there is a strong need for a formula that can increase itsstability. The aim of this study was to develop an approach for encapsulating Lycopene and investigate its effects oninflammatory markers, oxidative stress, and liver enzymes in patients with MetS.Materials and Methods: This study is a simple randomized, double-blind, objective-based clinical trial that involvedeighty subjects with MetS, who were equally and randomly assigned to two groups: one group received 20 mg ofLycopene per day for 8 weeks, and the Placebo group followed the same protocol as the Lycopene group but receiveda placebo instead of Lycopene. They were called Lycopene and placebo, respectively. During follow-up visits after 4and 8 weeks, 20 ml of blood was collected for evaluation of liver enzymes and some inflammatory related markers.

Results

Prior to the assignment of volunteers to their respective groups, there were no notable differences in C-reactiveprotein (CRP), serum liver enzymes, systolic and diastolic blood pressure, or pro-oxidant-antioxidant balance (PAB)between the Lycopene and placebo groups. However, our subsequent analysis revealed a significant reduction in theserum levels of CRP (P=0.001) and PAB (P=0.004) in the group that received Lycopene. Our encapsulated Lycopenetreatment was not associated with a significant difference in serum levels of alanine aminotransferase (ALT), aspartatetransferase (AST), or alkaline phosphatase (ALP) between our two groups.

Conclusion

This study investigated the impact of Lycopene on individuals with MetS, revealing a noteworthymodulation effect on PAB and inflammation linked to MetS. However, no significant differences was demonstrated inserum levels of ALT, AST and ALP between the studied group (registration number: IRCT20130507013263N3).

Schlagwörter

Stichwörter der Autor:innen

InflammationLiver EnzymeLycopeneMetabolic SyndromeOxidative Stress

Autor:innen und Institutionen

  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
  • Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Brighton and Sussex Medical School, Division of Medical Education, Brighton, UK.
  • Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Mahdi Mirahmadi, Malihe Aghasizadeh, Fatemeh Nazifkar, Mahla Ghafarian Choubdari, Reza Assaran-Darban, Shima Tavallaie, Hossein Hatamzadeh, Gordon Ferns, Mohammad Reza Mirinezhad, Hamed Baharara, Farzin Hadizadeh

Zitieren

APA

Mirahmadi, M., Aghasizadeh, M., Nazifkar, F., Ghafarian Choubdari, M., Assaran-Darban, R., Tavallaie, S., Hatamzadeh, H., Ferns, G., Mirinezhad, M. R., Baharara, H., Hadizadeh, F., & Ghayour-Mobarhan, M. (2023). The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial. Cell Journal, 25(12), 847-853. https://doi.org/10.22074/cellj.2023.2006158.1353

Vancouver

Mirahmadi M, Aghasizadeh M, Nazifkar F, Ghafarian Choubdari M, Assaran-Darban R, Tavallaie S, et al. The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial. Cell Journal. 2023;25(12):847-853. doi:10.22074/cellj.2023.2006158.1353

BibTeX
@article{Mirahmadi2023,
  author = {Mirahmadi, Mahdi and Aghasizadeh, Malihe and Nazifkar, Fatemeh and Ghafarian Choubdari, Mahla and Assaran-Darban, Reza and Tavallaie, Shima and Hatamzadeh, Hossein and Ferns, Gordon and Mirinezhad, Mohammad Reza and Baharara, Hamed and Hadizadeh, Farzin and Ghayour-Mobarhan, Majid},
  title = {The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial},
  journal = {Cell Journal},
  year = {2023},
  volume = {25},
  number = {12},
  pages = {847--853},
  doi = {10.22074/cellj.2023.2006158.1353}
}
Kostenlos starten →